Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-13

Clinical Trial Update: Effect of Solanum Melongena Extract in the Treatment of Arsenical Skin Lesion [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Solanum melongena extract for arsenical keratosis has completed, conducted by Bangabandhu Sheikh Mujib Medical University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Solanum melongena extract (Solanum melongena extract)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Arsenical Keratosis | Phase 2 | Status: COMPLETED